NEWS
New Feature!!!! University Subject Rankings in 12 branches
FOR SCIENTIST REGISTRATION FOR INSTITUTIONAL BULK REGISTRATION
FOR EDIT YOUR UNIVERSITY / INSTITUTION PAGE
Some differences of the AD Scientific Index
New Feature!!!! University Subject Rankings in 12 branches
List without CERN, Statistical Data etc. Only in AD Scientific Index
New Feature!!!! University Subject Rankings in 12 branches
AD
Scientific Index 2024
About Us
Methodology
Compare & Choose
Contact - FAQ
login
Login
person_add
Register
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
school
University Rankings
subject
University Subject Rankings
insights
Subject Rankings
place
Country Rankings
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
local_fire_department
Country Top Lists
Sai Hong Ignatius Ou
University of California Irvine - Irvine / United States
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 1748908
Edit Form
Registration, Add Profile,
Premium Membership
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Sai Hong Ignatius Ou's MOST POPULAR ARTICLES
1-)
Anaplastic lymphoma kinase inhibition in non–small-cell lung cancerEL Kwak, YJ Bang, DR Camidge, AT Shaw, B Solomon, RG Maki, SHI Ou, ...New England Journal of Medicine 363 (18), 1693-1703, 201050592010
2-)
Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung CancerS Peters, DR Camidge, AT Shaw, S Gadgeel, JS Ahn, DW Kim, SHI Ou, ...New England Journal of Medicine 377 (9), 829-838, 201719312017
3-)
Crizotinib in ROS1-rearranged non–small-cell lung cancerAT Shaw, SHI Ou, YJ Bang, DR Camidge, BJ Solomon, R Salgia, GJ Riely, ...New England Journal of Medicine 371 (21), 1963-1971, 201419102014
4-)
ROS1 Rearrangements Define a Unique Molecular Class of Lung CancersK Bergethon, AT Shaw, SH Ignatius Ou, R Katayama, CM Lovly, ...Journal of clinical oncology 30 (8), 863-870, 201219732012
5-)
Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 studyDR Camidge, YJ Bang, EL Kwak, AJ Iafrate, M Varella-Garcia, SB Fox, ...The lancet oncology 13 (10), 1011-1019, 201215462012
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept